- Home
- ETON vs CPS Comparison
ETON vs CPS Comparison
Compare ETON & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CPS
- Stock Information
- Founded
- ETON 2017
- CPS 1960
- Country
- ETON United States
- CPS United States
- Employees
- ETON N/A
- CPS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- ETON Health Care
- CPS Consumer Discretionary
- Exchange
- ETON Nasdaq
- CPS Nasdaq
- Market Cap
- ETON 498.8M
- CPS 462.2M
- IPO Year
- ETON 2018
- CPS N/A
- Fundamental
- Price
- ETON $18.35
- CPS $32.34
- Analyst Decision
- ETON Strong Buy
- CPS Buy
- Analyst Count
- ETON 3
- CPS 2
- Target Price
- ETON $29.67
- CPS $26.50
- AVG Volume (30 Days)
- ETON 249.9K
- CPS 188.6K
- Earning Date
- ETON 11-06-2025
- CPS 10-30-2025
- Dividend Yield
- ETON N/A
- CPS N/A
- EPS Growth
- ETON N/A
- CPS N/A
- EPS
- ETON N/A
- CPS 1.65
- Revenue
- ETON $58,181,000.00
- CPS $2,719,148,000.00
- Revenue This Year
- ETON $105.25
- CPS $2.31
- Revenue Next Year
- ETON $40.84
- CPS $3.69
- P/E Ratio
- ETON N/A
- CPS $21.72
- Revenue Growth
- ETON 85.40
- CPS N/A
- 52 Week Low
- ETON $8.24
- CPS $10.38
- 52 Week High
- ETON $23.00
- CPS $40.67
- Technical
- Relative Strength Index (RSI)
- ETON 45.34
- CPS 40.06
- Support Level
- ETON $18.00
- CPS $37.11
- Resistance Level
- ETON $18.92
- CPS $39.75
- Average True Range (ATR)
- ETON 0.83
- CPS 1.84
- MACD
- ETON -0.12
- CPS -0.07
- Stochastic Oscillator
- ETON 45.30
- CPS 15.26
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.